Trial in progress: A phase I trial of dual EZH 1/2 inhibitor valemetostat tosylate (DS3201b) in pediatric, adolescent, and young adult patients with malignant solid tumors.-MedSci.cn

Trial in progress: A phase I trial of dual EZH 1/2 inhibitor valemetostat tosylate (DS3201b) in pediatric, adolescent, and young adult patients with malignant solid tumors.

Arakawa, A; Ozawa, H; Hirakawa, A; Sadachi, R; Hoshina, Y; Tomatsuri, S; Saito, Y; Ando, RM; Terashima, K; Nakamura, K; Ogawa, C

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务